 Financing Agreement
June 3, 2024
Spero Therapeutics, Inc. recently announced the approval of 116,667 restricted stock unit awards to a new employee as an inducement under the 2019 Inducement Equity Incentive Plan. This grant was made in accordance with Nasdaq Listing Rule 5635(c)(4) and reflects the company s focus on identifying and developin...
|
Product Service News
June 3, 2024
Myriad Genetics, Inc., a renowned leader in genetic testing and precision medicine, has recently unveiled a breakthrough study published in Genetics in Medicine. This study validates RiskScore, an innovative breast cancer risk assessment tool embedded within Myriad s MyRisk Hereditary Cancer Test. RiskScore combines...
|
Clinical Study
June 3, 2024
SAN FRANCISCO, June 03, 2024 - FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company, has announced a clinical trial supply agreement with Regeneron Pharmaceuticals, a renowned pharmaceutical company specializing in innovative therapies. This collaboration aims to evaluate FibroGen s immuno-oncology ass...
|
|
 Announcement
June 3, 2024
Piedmont Office Realty Trust Demonstrates Strong Leasing Activity and Financial Performance in the Second Quarter of 2024 Piedmont Office Realty Trust (NYSE: PDM), a leading real estate investment trust (REIT), has witnessed impressive leasing activity during April and May 2024, signing leases for over 575,000 squar...
 Product Service News
June 3, 2024
Sun Communities, Inc., a prominent real estate investment trust (REIT), disclosed that its Board of Directors has approved a quarterly distribution of $0.94 per share of common stock for the second quarter of 2024. This distribution is applicable to shareholders recorded on or before June 28, 2024, and will be paid...
|
|
Our most Popular Articles
|
Announcement
June 11, 2024
Syntec Optics (Nasdaq: OPTX) Expands Optical Connectivity Solutions to Meet Growing Demand for Artificial Intelligence in Data Centers; Secures $1.3M in Orders for Microlens Array, Orders Expected to Double to $3.2MCity, Date - Syntec Optics, a leading provider of precision polymer optics, has recently announced sec...
|
Financing Agreement
March 18, 2024
Madrigal Pharmaceuticals Embarks on $500 Million Public Offering to Fuel Innovation in NASH Therapeutics
CONSHOHOCKEN, Pa., March 18, 2024 - Madrigal Pharmaceuticals, a leading biopharmaceutical company focused on groundbreaking treatments for nonalcoholic steatohepatitis (NASH), has recently unveiled its ...
|
Product Service News
August 5, 2024
Cyber Guardians: Fortinet s Robust Measures for Safeguarding Operational Technology In an era where the convergence of information technology (IT) and operational technology (OT) is both inevitable and transformative, ensuring the security of cyber-physical systems has become paramount. Digital transformation across...
|
|
|
Company News
|
Product Service News
June 3, 2024
Myriad Genetics, Inc., a renowned leader in genetic testing and precision medicine, has recently unveiled a breakthrough study published in Genetics in Medicine. This study validates RiskScore, an innovative breast cancer risk assessment tool embedded within Myriad s MyRisk Hereditary Cancer Test. RiskScore combines...
|
Clinical Study
June 3, 2024
SAN FRANCISCO, June 03, 2024 - FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company, has announced a clinical trial supply agreement with Regeneron Pharmaceuticals, a renowned pharmaceutical company specializing in innovative therapies. This collaboration aims to evaluate FibroGen s immuno-oncology ass...
|
Clinical Study
June 3, 2024
:This article discusses the ground-breaking research presented by Rhythm Pharmaceuticals at ENDO 2024, which provides vital insights into the patient experiences associated with hyperphagia in hypothalamic obesity. Hypothalamic obesity is a complex condition characterized by dysfunctional regulation of appetite, lea...
|
|
|
Company News
Clinical Study
June 3, 2024
|
Company News
 Clinical Study
June 3, 2024
|
Company News
 Financing Agreement
June 3, 2024
|
More Company News
|
Business Update
June 3, 2024
|
Business Update
June 3, 2024
|
Clinical Study
June 3, 2024
|
Business Update
June 3, 2024
|
Product Service News
June 3, 2024
|
Announcement
June 3, 2024
|
Business Update
June 3, 2024
|
Product Service News
June 3, 2024
|
Partnership
June 3, 2024
|
Clinical Study
June 3, 2024
|
|
|
|
Related News
|
Business Update
|
Business Update
|
|
Stocks
|
Business Update
|
Business Update
|
Business Update
|
|
|
|
Business News
|
 Announcement
Piedmont Office Realty Trust Demonstrates Strong Leasing Activity and Financial Performance in the Second Quarter of 2024 Piedmont Office Realty Trust (NYSE: PDM), a leading real estate investment trust (REIT), has witnessed impressive leasing activity during April and May 2024, signing leases for over 575,000 squar...
|
|
Product Service News
Sun Communities, Inc., a prominent real estate investment trust (REIT), disclosed that its Board of Directors has approved a quarterly distribution of $0.94 per share of common stock for the second quarter of 2024. This distribution is applicable to shareholders recorded on or before June 28, 2024, and will be paid...
|
 Product Service News
: Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a company at the forefront of developing innovative small molecule therapeutics, has recently announced the grant of equity inducement awards to new employees under the 2022 Employment Inducement Award Plan, as amended. This strategic move is aimed at attracting top-tie...
|
 Management Announcement
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
SAN FRANCISCO, June 03, 2024 - Structure Therapeutics Inc. (NASDAQ: GPCR), a leading biopharmaceutical company specializing in the development of innovative oral small molecule therapeutics for metabol...
|
 Financing Agreement
Spero Therapeutics, Inc. recently announced the approval of 116,667 restricted stock unit awards to a new employee as an inducement under the 2019 Inducement Equity Incentive Plan. This grant was made in accordance with Nasdaq Listing Rule 5635(c)(4) and reflects the company s focus on identifying and developin...
|
Our Most Popular Articles
|
 Announcement
Syntec Optics (Nasdaq: OPTX) Expands Optical Connectivity Solutions to Meet Growing Demand for Artificial Intelligence in Data Centers; Secures $1.3M in Orders for Microlens Array, Orders Expected to Double to $3.2MCity, Date - Syntec Optics, a leading provider of precision polymer optics, has recently announced sec...
|
 Financing Agreement
Madrigal Pharmaceuticals Embarks on $500 Million Public Offering to Fuel Innovation in NASH Therapeutics
CONSHOHOCKEN, Pa., March 18, 2024 - Madrigal Pharmaceuticals, a leading biopharmaceutical company focused on groundbreaking treatments for nonalcoholic steatohepatitis (NASH), has recently unveiled its ...
|
 Product Service News
Cyber Guardians: Fortinet s Robust Measures for Safeguarding Operational Technology In an era where the convergence of information technology (IT) and operational technology (OT) is both inevitable and transformative, ensuring the security of cyber-physical systems has become paramount. Digital transformation across...
|
More News
|
 Product Service News
Myriad Genetics, Inc., a renowned leader in genetic testing and precision medicine, has recently unveiled a breakthrough study published in Genetics in Medicine. This study validates RiskScore, an innovative breast cancer risk assessment tool embedded within Myriad s MyRisk Hereditary Cancer Test. RiskScore combines...
|
 Clinical Study
SAN FRANCISCO, June 03, 2024 - FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company, has announced a clinical trial supply agreement with Regeneron Pharmaceuticals, a renowned pharmaceutical company specializing in innovative therapies. This collaboration aims to evaluate FibroGen s immuno-oncology ass...
|
 Clinical Study
:This article discusses the ground-breaking research presented by Rhythm Pharmaceuticals at ENDO 2024, which provides vital insights into the patient experiences associated with hyperphagia in hypothalamic obesity. Hypothalamic obesity is a complex condition characterized by dysfunctional regulation of appetite, lea...
|
 Clinical Study
Ascendis Pharma Presents New Data on Promising Treatments at ASCO 2024Ascendis Pharma, a biopharmaceutical company based in Denmark, has recently presented new data and updated results from its clinical trials at the American Society of Clinical Oncology (ASCO) 2024 conference. The findings highlight the efficacy an...
|
|
Clinical Study
Eledon Unveils Promising Data from Phase 1b Trial of Tegoprubart for Kidney Transplant Rejection Prevention Eledon Pharmaceuticals, a trailblazing biotech firm dedicated to innovative immunotherapeutic solutions, recently unveiled updated data from their ongoing Phase 1b clinical trial evaluating the efficacy of teg...
|
 Financing Agreement
FTAI Aviation Announces Increase in Cash Tender Offer for 9.750% Senior Notes Due 2027 as Current Liabilities Rise
In a recent press release, FTAI Aviation has announced an increase in the cash tender offer for its 9.750% Senior Notes. This comes in the wake of an increase in current liabilities in the first qua...
|
 Business Update
Interactive Brokers Group, Inc. (Nasdaq: IBKR), a leading global automated electronic brokerage firm, has released its monthly performance metrics for May 2024, showcasing impressive highlights that reaffirm its position as a frontrunner in the industry.The company reported a noteworthy increase in its Daily Average...
|
 Business Update
Agilent Technologies, a leading provider of analytical instruments, announced two groundbreaking products at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. These advancements include the Agilent 7010D Triple Quadrupole GC/MS System, targeting the food and environmental sectors, and the Agilent ExD ...
|
|
Clinical Study
Merus N.V., a clinical-stage oncology company specializing in multispecific antibodies, showcased promising single-agent efficacy results for its investigational therapy MCLA-129 targeting MET exon 14 (METex14) non-small cell lung cancer (NSCLC) during the 2024 American Society of Clinical Oncology (ASCO) Annual Me...
|
 Business Update
Hilton Set to Dominate Lifestyle Hotel Category with Doubling of PortfolioHilton Worldwide Holdings Inc, a renowned leader in the hospitality industry, is set to make its mark on the rapidly growing lifestyle hotel category. With an ambitious plan to double its current portfolio of nearly 350 lifestyle hotels to 700...
|
 Product Service News
Inotiv, a prominent contract research organization, announced an agreement with regulatory authorities to resolve the previously disclosed investigation concerning its shuttered Cumberland, Virginia facility. The investigation focused on allegations related to non-compliance with animal welfare standards at the faci...
|
 Announcement
WISe.ART, a forward-thinking technology company, has recently partnered with the Sustainable Fashion Innovation Society (SFIS) to organize an upcoming Phygital Sustainability Expo. This exciting collaboration aims to showcase the intersection of sustainable practices and cutting-edge technology in the fashion indust...
|
 Business Update
Constl, a subsidiary of the Space World Group, has partnered with optical technology leader Ciena to significantly enhance digital connectivity across India. In a strategic move, Constl is deploying Ciena s advanced optical technology to develop a high-speed Metro Area Network (MAN) and National Long Distance (NLD) connectivity services on its sophisticated pan-India network. This groundbreaking initiative underscores a pivotal step toward bolstering India s digital infrastructure, improving internet speeds, and enhancing user experiences. High-Speed Connectivity: The Backbone of Modern IndiaThe collaboration emphasizes the deployment of Ciena s 6500 Packet-Optical Platform, driven by the cutting-edge WaveLogic 5 Extreme (WL5e) technology. At its core, this platform is designed to support services up to 800G today, which is a substantial leap in terms of data capacity and transmission speed. This infrastructure is not static; it has the scalability to support up to 1.6T services with the integration of WaveLogic 6 (WL6) technology in the future. This foresight ensures that the network can accommodate the growing data demands of a digitally evolving nation.
|
 Product Service News
Toll Brothers Opens Luxury Home Community in Punta Gorda, FloridaPUNTA GORDA, Fla., June 03, 2024 - Toll Brothers, Inc. (NYSE:TOL), the leading builder of luxury homes in the United States, has announced the opening of its Toll Brothers at Willow community in Punta Gorda, Florida. The homes are priced from the mid-$...
|
 Partnership
Expanding Partnerships: CN Supports Indigenous Athletes while Navigating a Challenging Market CSIMarket.com - June 3, 2024In a move to celebrate National Indigenous History Month, CN (TSX: CNR) (NYSE: CNI) has announced an expansion of its partnership with Canada s Sports Hall of Fame. This commitment aims to suppo...
|
 Clinical Study
Crinetics Presents Compelling Data Highlighting Potential of Paltusotine in Treating Acromegaly and Carcinoid SyndromeCrinetics Pharmaceuticals has recently unveiled promising data at ENDO 2024, providing further evidence that positions paltusotine as a potential first-choice treatment option for acromegaly and car...
|
|
|
|
|
